Why the study?
The AFEQT questionnaire is typically measured only once in AF, but serial assessments may better reflect disease burden and prognostic risk over time.
Does serial assessment of AFEQT scores predict all-cause death and heart failure hospitalization in stable outpatients with atrial fibrillation?
Cohort (n=2,743)
Yes
Does serial assessment of AFEQT scores predict all-cause death and heart failure hospitalization in stable outpatients with atrial fibrillation?
Serial assessment of patient-reported health status using the AFEQT questionnaire provides better prognostic value for mortality and heart failure hospitalization in atrial fibrillation patients than a single baseline measurement.
Answers are grounded in this paper and cite their sources.
Serial AFEQT assessment may refine prognostication in stable AF outpatients; leaves open whether monitoring improves outcomes or warrants trials.
Background: The Atrial Fibrillation Effect on Quality-of-Life (AFEQT) questionnaire is endorsed for symptom and quality-of-life assessment in atrial fibrillation (AF) but is typically measured once. Because patient-reported health status changes with treatment, serial AFEQT assessments may better reflect disease burden over time. We evaluated whether repeated AFEQT measurements are associated with subsequent outcomes and whether the most recent score is informative. Methods and Results: We analyzed a multicenter, prospective registry of stable outpatients with AF referred to 11 hospitals in Japan (2012–2018). Associations of baseline (“prior”), 12-month (“current”), and change in AFEQT overall summary (os) scores with all-cause death and heart failure (HF) hospitalization were examined using multivariable Cox models. Among 2,743 patients (mean [±SD] age 67.8±11.1 years; 31.9% women), 146 (5.3%) experienced HF hospitalization and 134 (4.9%) died over a median follow-up of 4.0 years. Higher current AFEQT-os and change scores, but not prior AFEQT-os, were associated with a lower risk of death/HF hospitalization, with adjusted hazard ratios (95% confidence intervals) per 5-point increase of 0.94 (0.91–0.97) and 0.96 (0.92–0.99), respectively. When modeled together, only current AFEQT-os remained independently associated with outcomes. In time-varying analyses, time-updated AFEQT-os predicted both death/HF hospitalization and all-cause death. Conclusions: The most recent AFEQT-os is associated with mortality and HF hospitalization, whereas baseline scores provide limited prognostic value. Updating patient-reported health status may help with risk assessment in AF.
No takes yet. Share an insight, caveat, or question.
Shiraishi et al. (2026) conducted a cohort in Atrial fibrillation (n=2,743). Current AFEQT overall summary score vs. Baseline AFEQT overall summary score was evaluated on all-cause death and heart failure (HF) hospitalization (HR 0.94, 95% CI 0.91-0.97).
Synapse has enriched 10 related papers. Consider them for comparative context: